Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein

被引：74

作者：

Starling, JJ ^{[1
]}

Shepard, RL ^{[1
]}

Cao, J ^{[1
]}

Law, KL ^{[1
]}

Norman, BH ^{[1
]}

Kroin, JS ^{[1
]}

Ehlhardt, WJ ^{[1
]}

Baughman, TM ^{[1
]}

Winter, MA ^{[1
]}

Bell, MG ^{[1
]}

Shih, C ^{[1
]}

Gruber, J ^{[1
]}

Elmquist, WF ^{[1
]}

Dantzig, AH ^{[1
]}

机构：

[1] UNIV NEBRASKA, MED CTR, DEPT PHARMACEUT SCI, OMAHA, NE 68198 USA

来源：

ADVANCES IN ENZYME REGULATION, VOL 37 | 1997年 / 37卷

关键词：

D O I：

10.1016/S0065-2571(96)00021-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：335 / 347

页数：13

共 20 条

[1] RESTORATION OF DAUNOMYCIN RETENTION IN MULTIDRUG-RESISTANT P388 CELLS BY SUBMICROMOLAR CONCENTRATIONS OF SDZ PSC-833, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE DERIVATIVE [J].

BOESCH, D ;

MULLER, K ;

POURTIERMANZANEDO, A ;

LOOR, F .

EXPERIMENTAL CELL RESEARCH, 1991, 196 (01) :26-32

[2]

BOESCH D, 1991, CANCER RES, V51, P4226

[3] What have we learnt thus far from mice with disrupted P-glycoprotein genes? [J].

Borst, P ;

Schinkel, AH .

EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :985-990

[4]

Dantzig AH, 1996, CANCER RES, V56, P4171

[5] PHARMACOLOGICAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE [J].

FORD, JM ;

HAIT, WN .

CYTOTECHNOLOGY, 1993, 12 (1-3) :171-212

[6]

FORD JM, 1990, PHARMACOL REV, V42, P155

[7]

GOLDSTEIN L, 1995, CURR PROB CANCER, V19, P67

[8]

HYAFIL F, 1993, CANCER RES, V53, P4595

[9]

LONGNECKER SM, 1987, CANCER TREAT REP, V71, P53

[10]

LUM BL, 1993, CANCER, V72, P3502, DOI 10.1002/1097-0142(19931201)72:11+<3502::AID-CNCR2820721618>3.0.CO

← 1 2 →